Outsourced Pharma Capacity Update

Your CDMO Capacity Search Starts Here.

It's more than a slogan. At Outsourced Pharma, we understand the incredible amount of time and effort it takes to find the right partner. That's why we created our Capacity Update Partner Week.

January 2025 Registration Now Open

Short, digestible, digital presentations with live interaction give you an inside look at the capabilities and capacities of industry suppliers. You will have the opportunity to ask questions of each CDMO to understand if they can meet your needs and timeline - all from the convenience of your computer!

This multi-day event is conveniently grouped by capability. Register for only the day(s) that feature partners with the services to match your outsourcing needs.

Can't join us live? All registrants (even those unable to attend the live presentations) will receive early access to the on-demand recordings 24 hours post-event.

We're here to help! Contact Outsourced Pharma for assistance connecting with CDMOs you're interested in exploring further.

January 2025 Partner Week

Tue. 1/28 - Large Molecule Drug Substance
Presentations begin at 10am ET (7am PT)

Mabion: Journey through Mabion's GMP-certified facility, and learn about its expanded capabilities dedicated to large molecule development, recently released capacity of advanced bioreactors, and state-of-the-art analytical portfolio.
Cytovance Biologics: Engage in this presentation on capabilities and available capacity in microbial and mammalian biologics development as Cytovance Biologics showcases its latest offerings.
Catalent: Discover how Catalent leverages its extensive expertise and capabilities to deliver tailored solutions to meet specific analytical needs for biotherapeutics.
Northway Biotech: Glean new insights into Northway Biotech's capabilities, competitive advantages, and current capacity to onboard new projects at its Waltham, MA and Vilnius, Lithuania facilities as it continues to expand on its portfolio of more than 175 projects over a 20-year history.
KBI Biopharma: Explore how innovations in automation and process development digitization have helped KBI Biopharma's customers overcome complex biomanufacturing challenges, with a demonstration on how its high-throughput technologies and digital tools enhance process understanding and streamline decision-making.

Wed. 1/29 - Small Molecule
Presentations begin at 2pm ET (11am PT)

Ajinomoto Bio-pharma: Explore new possibilities with an expert review of advancements in Ajinomoto Bio-pharma's development and manufacturing capabilities for HPAPI, clinical development and late-stage projects.
Upperton Pharma Solutions: UK-based CDMO, Upperton, specializing in oral solids, nasal and pulmonary drug development and manufacture, showcases its expertise, project delivery approach, capabilities and technology, and delivers a tour of its award-winning 50,000 sq. ft development and manufacturing facility.
Douglas CDMO: New Zealand-based Douglas CDMO brings its latest in capabilities and capacities across key therapeutic areas, including oncology, dermatology, the central nervous system, and immunity.
Alcami: Solid-state characterization, non-GMP analytical testing, clinical manufacturing, and stability studies are but a few of the capabilities in Alcami's broad scope of operations up for discussion during its small molecule capacity update.

Thu. 1/30 - Cell & Gene Therapy
Presentations begin at 10am ET (7am PT)

Andelyn: An Introduction to Laboratory Services at Andelyn: Learn how team synergies and an unwavering focus on GMP analytics ensure the integrity of clinical-phase productions at Andelyn's labs.
Forge Biologics, a member of Ajinomoto Bio-Pharma Services: See how Forge's dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.
Aldevron: Explore Aldevron's groundbreaking Alchemy™ cell-free DNA technology, the next-generation solution for rapid and efficient DNA template for mRNA manufacturing, and how it’s cutting production timelines by over 50%.

Fri. 1/31 - Fill/Finish
Presentations begin at 10am ET (7am PT)

Ajinomoto Bio-pharma: Survey Ajinomoto Bio-Pharma Services' range of fill/finish offerings at its San Diego, CA facilities, including its high-speed, multi-purpose fill finish line for vials, syringes, and cartridges; as well as its capabilities to handle highly-potent and/or cytotoxic substances.
Jubilant HollisterStier: Learn how sterile injectables, lyophilized products, and ophthalmics meet the highest levels of quality, compliance, and reliability in contract manufacturing with Jubilant HollisterStier's capacity and capabilities update.
Lifecore Biomedical: Hear about Lifecore Biomedical's recently expanded capacity before taking an in-depth look at the benefits of its new, multi-container isolator filler which minimizes line loss of valuable APIs and Biologics.
FUJIFILM Diosynth Biotechnologies: Traverse FUJIFILM Diosynth Biotechnologies' latest work and partnerships and learn how its current and future state of drug product and finished goods capabilities and capacity create an end-to-end service experience.
Alcami: Brush up on Alcami's fill/finish capabilities and capacity across formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing as it showcases its latest CDMO offerings.
Lonza: Delve into Lonza Biologics' recent expansions at its site in Switzerland including its biologics filling in vials -as liquid or lyophilizates-, as well as in prefilled syringes (PFS) and cartridges and its new highly potent ADC manufacturing capabilities.

January 2025 Partner Week Presenters

Day One
Large Molecule Drug Substance
Capacity Presentations

Day Two
Small Molecule
Capacity Presentations

Day Three
Cell & Gene Therapy
Capacity Presentations

Day Four
Fill/Finish
Capacity Presentations

Our quarterly Outsourced Pharma Capacity Update Partner Week offers sessions grouped by capability for an ultra-convenient way to see current partner capacities related to your specific outsourcing requirements. Join only the session(s) that best suits your outsourcing needs. Each CDMO presentation will last approximately 20 minutes.

If you have the authority to choose and/or manage CDMO relationships and need to secure capacity for your development or commercial programs, this capacity update is essential. Outsourced Pharma’s goal is to make your vetting process more efficient by presenting multiple options in a condensed time period.

Are you a supplier looking to present at our next event?

Become A Presenter

Registrants will receive reminder emails leading up to the event, including two on the day of the event. If you are not receiving these emails or have trouble accessing the event link, use the appropriate link below.

Tue. 1/28/25 - Large Molecule Drug Substance
Wed. 1/29/25 - Small Molecule
Thu. 1/30/25 - Cell & Gene Therapy
Fri. 1/31/25 - Fill/Finish

On the registration page, click “Already Registered?” in the top right column, and enter the email used during registration.
If you have not registered or forgot the email used, please complete the registration form again to access the event.